Friday, December 30, 2022

Congress faults US regulator’s approval of Biogen Alzheimer’s drug

Committees cite inappropriate collaboration between FDA and drugmaker

from News Feed https://ift.tt/WFHazA1
via IFTTT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)